70
Participants
Start Date
April 24, 2019
Primary Completion Date
August 26, 2019
Study Completion Date
August 26, 2019
ATR-002 MEK Inhibitor
Drug ATR-002 administered as film-coated tablet via oral route
Placebo oral tablet
Placebo film-coated tablet administered via oral route
SGS Life Sciences, Clinical Pharmacology Unit Antwerpen, Antwerp
Lead Sponsor
SGS Life Sciences, a division of SGS Belgium NV
OTHER
Atriva Therapeutics GmbH
INDUSTRY